Roivant Sciences (ROIV) director granted 543 fully vested common shares

Rhea-AI Filing Summary

Epperly Melissa B, reported acquisition or exercise transactions in this Form 4 filing.

Roivant Sciences Ltd. director Melissa B. Epperly received a grant of 543 Common Shares on July 17, 2026 under the company’s Non-Employee Director Compensation Plan. The award was fully vested at grant and increased her directly held stake to 17,017 Common Shares.

Insider Trade Summary

Net Buyer: 543 shares

Net Buy 1 txn

Insider Epperly Melissa B,

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Shares F1	543	$0.00	$0.00

Holdings After Transaction: Common Shares — 17,017 shares (Direct)

Footnotes (1)

1. F1. Reflects an award of Common Shares received pursuant to the Issuer's Non-Employee Director Compensation Plan that was fully vested as of the grant date.

Key Figures

Shares awarded: 543 Common Shares Holdings after transaction: 17,017 Common Shares Reported transaction price: 0.0000 per share +1 more

4 metrics

Shares awarded 543 Common Shares Equity award to director on 2026-07-17

Holdings after transaction 17,017 Common Shares Direct ownership by Melissa B. Epperly following award

Reported transaction price 0.0000 per share Grant/award acquisition of Common Shares

Transaction date 2026-07-17 Grant date of Common Share award

Key Terms

Non-Employee Director Compensation Plan, Common Shares, fully vested, Power of Attorney

4 terms

Non-Employee Director Compensation Plan financial

"received pursuant to the Issuer's Non-Employee Director Compensation Plan"

Common Shares financial

"Reflects an award of Common Shares received pursuant to the Issuer's"

Common shares are the basic units of ownership in a company that give holders a claim on profits and a right to vote on key matters, like electing the board. Think of them as membership cards in a club: they let you share in successes and losses, but in a bankruptcy or liquidation they are paid after creditors and preferred shareholders, so their value can swing more and matters for assessing risk and potential return.

fully vested financial

"that was fully vested as of the grant date"

Power of Attorney regulatory

"Exhibit 24 - Power of Attorney"

A power of attorney is a legal document that allows one person to make decisions and act on behalf of another person, often in financial or legal matters. It’s like giving someone a trusted helper or agent the authority to handle important tasks if you are unable to do so yourself. This matters to investors because it can impact how their assets are managed or transferred if they become unable to oversee their affairs.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/21/2026 - 09:00 PM Accepted by SEC EDGAR 07/21/2026 - 09:00 PM Learn about SEC filing dates

FAQ

What insider transaction did Roivant Sciences (ROIV) report for Melissa B. Epperly?

Melissa B. Epperly reported receiving 543 Common Shares of Roivant Sciences Ltd. as a fully vested equity award. The grant was made under the company’s Non-Employee Director Compensation Plan and is classified as a direct holding of common shares.

When did the latest reported insider share award at Roivant Sciences (ROIV) occur?

The reported insider share award occurred on July 17, 2026. On that date, director Melissa B. Epperly received 543 fully vested Common Shares under Roivant Sciences Ltd.’s Non-Employee Director Compensation Plan, increasing her directly held share position.

How many Roivant Sciences (ROIV) shares does Melissa B. Epperly hold after the grant?

After the grant, Melissa B. Epperly holds 17,017 Common Shares of Roivant Sciences Ltd. These shares are reported as directly owned and include the 543 Common Shares awarded on July 17, 2026 under the Non-Employee Director Compensation Plan.

What was the nature of the 543-share transaction reported at Roivant Sciences (ROIV)?

The 543-share transaction was a grant or award acquisition of Common Shares, not an open-market purchase. It was issued as director compensation under Roivant Sciences Ltd.’s Non-Employee Director Compensation Plan and was fully vested on the grant date.

Was the Roivant Sciences (ROIV) insider transaction part of a director compensation program?

Yes. The transaction reflects an award of Common Shares received under Roivant Sciences Ltd.’s Non-Employee Director Compensation Plan. The footnote specifies that the shares were granted as director compensation and were fully vested when granted.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Epperly Melissa B,

(Last) (First) (Middle)

C/O ROIVANT SCIENCES LTD.

7TH FLOOR, 50 BROADWAY

(Street)

LONDON SW1H 0DB

(City) (State) (Zip)

UNITED KINGDOM

(Country)

2. Issuer Name and Ticker or Trading Symbol
Roivant Sciences Ltd. [ ROIV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	07/17/2026		A		543(1)	A	$0(1)	17,017	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects an award of Common Shares received pursuant to the Issuer's Non-Employee Director Compensation Plan that was fully vested as of the grant date.

Remarks:

Exhibit 24 - Power of Attorney

	By: /s/ Sam Kaplan, as Attorney-in-Fact for Melissa Epperly	07/21/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)